254 related articles for article (PubMed ID: 20008709)
1. Melanoma-associated retinopathy: a paraneoplastic autoimmune complication.
Lu Y; Jia L; He S; Hurley MC; Leys MJ; Jayasundera T; Heckenlively JR
Arch Ophthalmol; 2009 Dec; 127(12):1572-80. PubMed ID: 20008709
[TBL] [Abstract][Full Text] [Related]
2. Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases.
Keltner JL; Thirkill CE; Yip PT
J Neuroophthalmol; 2001 Sep; 21(3):173-87. PubMed ID: 11725182
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to transducin in a patient with melanoma-associated retinopathy.
Potter MJ; Adamus G; Szabo SM; Lee R; Mohaseb K; Behn D
Am J Ophthalmol; 2002 Jul; 134(1):128-30. PubMed ID: 12095824
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
Adamus G; Ren G; Weleber RG
BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
[TBL] [Abstract][Full Text] [Related]
5. Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV.
Ladewig G; Reinhold U; Thirkill CE; Kerber A; Tilgen W; Pföhler C
Br J Dermatol; 2005 May; 152(5):931-8. PubMed ID: 15888149
[TBL] [Abstract][Full Text] [Related]
6. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma.
Weinstein JM; Kelman SE; Bresnick GH; Kornguth SE
Ophthalmology; 1994 Jul; 101(7):1236-43. PubMed ID: 8035987
[TBL] [Abstract][Full Text] [Related]
8. A case of melanoma-associated retinopathy with autoantibodies against TRPM1.
Kim MS; Hong HK; Ko YJ; Park KH; Ueno S; Okado S; Woo SJ; Joo K
Doc Ophthalmol; 2020 Dec; 141(3):313-318. PubMed ID: 32472235
[TBL] [Abstract][Full Text] [Related]
9. Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea.
Choi EY; Kim M; Adamus G; Koh HJ; Lee SC
Yonsei Med J; 2016 Mar; 57(2):527-31. PubMed ID: 26847311
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic vitelliform retinopathy: clinicopathologic correlation and review of the literature.
Aronow ME; Adamus G; Abu-Asab M; Wang Y; Chan CC; Zakov ZN; Singh AD
Surv Ophthalmol; 2012 Nov; 57(6):558-64. PubMed ID: 22784677
[TBL] [Abstract][Full Text] [Related]
11. Slowly progressive non-neoplastic autoimmune-like retinopathy.
Ohta K; Kikuchi T; Yoshida N
Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):155-8. PubMed ID: 20625760
[No Abstract] [Full Text] [Related]
12. Melanoma-associated paraneoplastic retinopathy: case report and review of the literature.
Boeck K; Hofmann S; Klopfer M; Ian U; Schmidt T; Engst R; Thirkill CE; Ring J
Br J Dermatol; 1997 Sep; 137(3):457-60. PubMed ID: 9349350
[TBL] [Abstract][Full Text] [Related]
13. The photoreceptor cell-specific nuclear receptor is an autoantigen of paraneoplastic retinopathy.
Eichen JG; Dalmau J; Demopoulos A; Wade D; Posner JB; Rosenfeld MR
J Neuroophthalmol; 2001 Sep; 21(3):168-72. PubMed ID: 11725181
[TBL] [Abstract][Full Text] [Related]
14. Retinal findings in melanoma-associated retinopathy.
Borkowski LM; Grover S; Fishman GA; Jampol LM
Am J Ophthalmol; 2001 Aug; 132(2):273-5. PubMed ID: 11476700
[TBL] [Abstract][Full Text] [Related]
15. Melanoma-associated retinopathy: does autoimmunity prolong survival?
Chan C; O'Day J
Clin Exp Ophthalmol; 2001 Aug; 29(4):235-8. PubMed ID: 11545422
[TBL] [Abstract][Full Text] [Related]
16. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease.
Whitcup SM; Vistica BP; Milam AH; Nussenblatt RB; Gery I
Am J Ophthalmol; 1998 Aug; 126(2):230-7. PubMed ID: 9727517
[TBL] [Abstract][Full Text] [Related]
17. Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction.
Kondo M; Sanuki R; Ueno S; Nishizawa Y; Hashimoto N; Ohguro H; Yamamoto S; Machida S; Terasaki H; Adamus G; Furukawa T
PLoS One; 2011; 6(5):e19911. PubMed ID: 21611200
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic vitelliform retinopathy associated with cutaneous or uveal melanoma and metastases.
Sotodeh M; Paridaens D; Keunen J; van Schooneveld M; Adamus G; Baarsma S
Klin Monbl Augenheilkd; 2005 Nov; 222(11):910-4. PubMed ID: 16308825
[TBL] [Abstract][Full Text] [Related]
19. Combination Treatment with Rituximab and Bortezomib in a Patient with Non-Paraneoplastic Autoimmune Retinopathy.
Benson MD; Plemel DJA; Yacyshyn E; Sandhu I; MacDonald IM; Baker CF
Ocul Immunol Inflamm; 2020 Aug; 28(6):958-965. PubMed ID: 31418623
[TBL] [Abstract][Full Text] [Related]
20. Anti-retinal pigment epithelium antibodies in acute exudative polymorphous vitelliform maculopathy: a new hypothesis about disease pathogenesis.
Koreen L; He SX; Johnson MW; Hackel RE; Khan NW; Heckenlively JR
Arch Ophthalmol; 2011 Jan; 129(1):23-9. PubMed ID: 21220625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
